<DOC>
	<DOCNO>NCT00267072</DOCNO>
	<brief_summary>The objective study : - To identify woman increase risk develop ovarian cancer - To detect ovarian cancer early stage - To investigate role tumor membrane fragment tumor marker early ovarian carcinoma</brief_summary>
	<brief_title>Ovarian Screening Study</brief_title>
	<detailed_description>In year 2001 approximately 23,400 woman USA expect diagnosed ovarian carcinoma 13,900 die disease . This mean within USA woman die annually ovarian cancer gynecologic malignancy combine . Within Commonwealth Kentucky approximately 250 woman per year develop ovarian carcinoma . Survival patient ovarian cancer directly relate stage disease diagnosis . Unfortunately , majority woman present advanced disease ( Stage III IV ) patient die disease . The aim screen ovarian cancer reduce morbidity mortality detect disease early stage since ovarian cancer detect disease confine ovary ( Stage I ) associate dramatically improve 5-year survival . Disease confine ovary may cure 90 % patient , case without need chemotherapy .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Asymptomatic woman age 45 one ovary . Women age 25 one ovary follow : A personal history breast , colon endometrial cancer breast cancer gene ( BRCA ) 1 2 positive Firstdegree relative ( mother , sister , daughter ) ovarian breast cancer Two family member either breast and/or ovarian cancer Mother , sister , daughter , grandparent positive BRCA1 BRCA2 genetic test result . Past use fertility drug Clomid Pergonal year . Women symptomatic ovarian cancer</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Ovarian Cancer</keyword>
</DOC>